Clinical Trial Update: Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether switching to mycophenolate mofetil with rapamycin versus continuing calcineurin inhibitors improves outcomes in kidn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Rapamycin (sirolimus)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED | Results posted: 2017-04-06